| Business Name: |
Promesa Drug Rehabilitation Cn |
| Address: |
1776 Clay Avenue, New York City, New York 10001 |
| Phone Number: |
(757) 405-3079 |
| Annual Revenue (USD): |
$100.000 to $499.999 |
| Founding Year: |
2007 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
|
| SIC Code: |
5912 |
| NAICS Code: |
446110 |
| Share This Business: |
|
| Related Businesses: |
Drug Trails Florida Inc - New York City, NY 10001
Duane Reade - New York City, NY 10001
Duane Reade - New York City, NY 10001
Harris & Klein - New York City, NY 10001
Duane Reade - New York City, NY 10001
Central Fill Pharmacy Inc - New York City, NY 10001
Infu Rx - New York City, NY 10001
Rexall Showcase Master Independent Distribution - New York City, NY 10001
Us Medicine Care - New York City, NY 10001
Top Drug Mart24 - New York City, NY 10001
Marpel Inc - New York City, NY 10001
Rapheal Drug & Health Ltd - New York City, NY 10001
Drug Policy Action - New York City, NY 10001
Ahf Pharmacy - New York City, NY 10001
Duane Reade - New York City, NY 10001
Duane Reade - New York City, NY 10001
Cici Pharmacy Inc - New York City, NY 10001
Eureka - New York City, NY 10001
Duane Reade - New York City, NY 10001
Duane Reade - New York City, NY 10001
|
The company Promesa Drug Rehabilitation Cn provides B2C services in the form of from its single location in New York.
1 to 4 employees work for Promesa Drug Rehabilitation Cn, and the business now earns $100.000 to $499.999 per annum.
Promesa Drug Rehabilitation Cn was launched in 2007 and is classified under SIC code and category 5912 , and NAICS number and grouping 446110 .
To contact Promesa Drug Rehabilitation Cn, please call with the phone number (757) 405-3079 or visit its single location at 1776 Clay Avenue in New York City, New York 10001.
The location of the single location can also be found using the coordinates .
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.